Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 17-(ethylthio)-9-fluoro-11-hydroxy-17-(methylthio)androsta-1,4-dien-3-one
2. Sq 27239
3. Sq-27239
1. 85197-77-9
2. Sq-27239
3. Sq 27,239
4. Tipredane (usan)
5. 169d68e13p
6. Tipredane [usan]
7. Tipredanum
8. Tipredano
9. Brn 4823918
10. Tipredanum [latin]
11. Tipredano [spanish]
12. Tipredane [usan:inn:ban]
13. Unii-169d68e13p
14. Tipredane [inn]
15. Schembl9569097
16. Chembl1908322
17. Chebi:175291
18. Dtxsid101318657
19. Zinc4214473
20. Bdbm50369181
21. 9-fluoro-11beta-hydroxyandrosta-1,4-diene-3,17-dione (17r)-17-(ethyl Methyl Mercaptole)
22. (11-beta,17-alpha)-17-(ethylthio)-9-fluoro-11-hydroxy-17-(methylthio)androsta-1,4-dien-3-one
23. (8s,9r,10s,11s,13s,14s,17r)-17-ethylsulfanyl-9-fluoro-11-hydroxy-10,13-dimethyl-17-methylsulfanyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
24. D06161
25. Q27251795
26. 1-ethyl-2-methyl-1h-benzoimidazole-5-carboxylicacidethylester
27. (8s,9r,10s,11s,13s,14s,17r)-17-ethylsulanyl-9-luoro-11-hydroxy-10,13-dimethyl-17-methylsulanyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
28. Androsta-1,4-dien-3-one, 17-(ethylthio)-9-fluoro-11-hydroxy-17-(methylthio)-, (11.beta.,17.alpha.)-
29. Androsta-1,4-dien-3-one, 17-(ethylthio)-9-fluoro-11-hydroxy-17-(methylthio)-, (11beta,17alpha)-
| Molecular Weight | 410.6 g/mol |
|---|---|
| Molecular Formula | C22H31FO2S2 |
| XLogP3 | 4.3 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 3 |
| Exact Mass | 410.17495074 g/mol |
| Monoisotopic Mass | 410.17495074 g/mol |
| Topological Polar Surface Area | 87.9 Ų |
| Heavy Atom Count | 27 |
| Formal Charge | 0 |
| Complexity | 721 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 7 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Tipredane manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tipredane, including repackagers and relabelers. The FDA regulates Tipredane manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tipredane API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Tipredane supplier is an individual or a company that provides Tipredane active pharmaceutical ingredient (API) or Tipredane finished formulations upon request. The Tipredane suppliers may include Tipredane API manufacturers, exporters, distributors and traders.
click here to find a list of Tipredane suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Tipredane DMF (Drug Master File) is a document detailing the whole manufacturing process of Tipredane active pharmaceutical ingredient (API) in detail. Different forms of Tipredane DMFs exist exist since differing nations have different regulations, such as Tipredane USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Tipredane DMF submitted to regulatory agencies in the US is known as a USDMF. Tipredane USDMF includes data on Tipredane's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Tipredane USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Tipredane suppliers with USDMF on PharmaCompass.
Tipredane Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tipredane GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tipredane GMP manufacturer or Tipredane GMP API supplier for your needs.
A Tipredane CoA (Certificate of Analysis) is a formal document that attests to Tipredane's compliance with Tipredane specifications and serves as a tool for batch-level quality control.
Tipredane CoA mostly includes findings from lab analyses of a specific batch. For each Tipredane CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tipredane may be tested according to a variety of international standards, such as European Pharmacopoeia (Tipredane EP), Tipredane JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tipredane USP).
LOOKING FOR A SUPPLIER?
